Vivo Opportunity Fund Holdings, L.P. sold $124.4M of Soleno Therapeutics (SLNO)

Executed Mar 26 2025, disclosed Mar 28 2025, 2 days later.

Value, as filed

$124.4M

1,833,557 sh across 3 lots

Executed

Mar 26 2025

the trade date, as filed

Disclosed

Mar 28 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

VP Vivo Opportunity Fund Holdings, L.P. 10% owner profile →

Vivo Opportunity Fund Holdings, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in SLNO. The largest single filing was $124.4M of SLNO (1,833,557 sh across 3 lots, as filed), executed Mar 26 2025.

The name

SLNO SLNO SLNO · 19 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→